The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) Return on equity
The Chemours Company's return on equity over the twelve months to 30 September 2026 was −67.5%, up 26.3 percentage points from fiscal 2025 (−93.8%). Over the past ten years it has ranged from −93.8% (fiscal 2025) to 154.0% (fiscal 2017) — the current reading is the lowest in ten years. That is below the Specialty Chemicals industry median of 2.34% and below the Basic Materials sector median of 0.00%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | −93.8% | (104.33) |
| FY2024 | 10.5% | 37.94 |
| FY2023 | −27.4% | (80.22) |
| FY2022 | 52.8% | (11.29) |
| FY2021 | 64.1% | 35.09 |
| FY2020 | 29.0% | 35.07 |
| FY2019 | −6.06% | (111.63) |
| FY2018 | 105.6% | (48.40) |
| FY2017 | 154.0% | 147.99 |
| FY2016 | 5.98% | 10.71 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| NGVT Ingevity Corporation compare | 64.4% |
| WDFC WD-40 Company compare | 30.4% |
| IOSP Innospec Inc. compare | 10.5% |
| FUL H. B. Fuller Company compare | 9.58% |
| KWR Quaker Houghton compare | 6.98% |
| SCL Stepan Company compare | 0.00% |
| MTX Minerals Technologies Inc. compare | −7.75% |
| CC The Chemours Company | −67.5% |
| STDN Standard Nuclear Inc compare | — |
| Specialty Chemicals industry median | 2.34% |
| Basic Materials sector median | 0.00% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement